A. Galaznik

发表

Association of Out-of-Pocket Pharmacy Costs with Adherence to Varenicline

K. Zou, C. Davis, B. Suehs, 2014, Journal of managed care & specialty pharmacy.

Impact of access restrictions on varenicline utilization

K. Zou, G. Lenhart, A. Galaznik, 2013, Expert review of pharmacoeconomics & outcomes research.

Burden of smoking on quality of life in patients with chronic obstructive pulmonary disease

K. Zou, A. Galaznik, J. Vietri, 2013, Expert review of pharmacoeconomics & outcomes research.

Impact of Out-of-pocket Costs on Varenicline Utilization and Persistence

K. Zou, G. Lenhart, A. Galaznik, 2014 .

Survival of blacks and whites after a cancer diagnosis.

Colin B Begg, Deborah Schrag, Peter B Bach, 2002, JAMA.

A pragmatic patient-reported outcome strategy for rare disease clinical trials: application of the EORTC item library to myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

R. Bejar, D. Faller, P. Marquis, 2019, Journal of Patient-Reported Outcomes.

Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care

D. Faller, M. Eaddy, A. Galaznik, 2018, Leukemia & lymphoma.

Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States

D. Faller, M. Eaddy, A. Galaznik, 2018, PharmacoEconomics - Open.

Relationship between age and erectile dysfunction diagnosis or treatment using real‐world observational data in the USA

K. Zou, A. Galaznik, V. Stecher, 2016, International journal of clinical practice.

A retrospective study evaluating treatment patterns and survival outcomes in elderly patients with acute myeloid leukemia treated in the United States with either 7+3 or a hypomethylating agent.

D. Faller, M. Eaddy, A. Galaznik, 2019, Leukemia research.

Adherence to Varenicline and Associated Smoking Cessation in a Community-Based Patient Setting

K. Zou, J. Liberman, H. Kirchner, 2013, Journal of managed care pharmacy : JMCP.

Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials.

K. Zou, J. Hughes, A. Berg, 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Economic burden and treatment patterns for patients with diffuse large B-cell lymphoma and follicular lymphoma in the USA.

C. Asche, A. Galaznik, Jinma Ren, 2019, Journal of comparative effectiveness research.

Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher‐Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

M. Stokes, D. Faller, Yelan Guo, 2018, Clinical lymphoma, myeloma & leukemia.

Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review

M. Stokes, D. Faller, Yelan Guo, 2018, Clinical lymphoma, myeloma & leukemia.

Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care

C. Reich, G. Hather, A. Galaznik, 2019, Cancer informatics.

Gastrointestinal complications in patients treated with ipilimumab and nivolumab combination therapy or monotherapy.

A. Galaznik, D. Irwin, J. Bell, 2019, Journal of comparative effectiveness research.

Meta-analytical methods for estimating outcomes from overall response rate in patients with relapsed/refractory diffuse large B-cell lymphoma

A. Galaznik, Y. Shou, Ling Wang, 2019, Oncotarget.

Treatment approaches for older and oldest patients with diffuse large B-cell lymphoma - Use of non-R-CHOP alternative therapies and impact of comorbidities on treatment choices and outcome: A Humedica database retrospective cohort analysis, 2007-2015.

V. Morrison, A. Galaznik, A. Raju, 2019, Journal of geriatric oncology.

Systematic review of therapy used in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma

M. Stokes, Yelan Guo, A. Galaznik, 2018, Future science OA.

Treatment Patterns and Survival Outcomes in Patients With Follicular Lymphoma: A 2007 to 2015 Humedica Database Study

V. Morrison, M. Eaddy, A. Galaznik, 2019, Clinical lymphoma, myeloma & leukemia.

Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review

A. Galaznik, E. Mearns, J. Bell, 2018, Melanoma management.

Economic burden of elderly patients with acute myeloid leukemia treated in routine clinical care in the United States.

D. Faller, M. Eaddy, A. Galaznik, 2018, Leukemia research.

Evaluation of treatment patterns and survival among patients with diffuse large B-cell lymphoma in the USA.

V. Morrison, M. Eaddy, A. Galaznik, 2019, Future oncology.

Economic burden of patients with diffuse large B-cell and follicular lymphoma treated in the USA.

V. Morrison, M. Eaddy, A. Galaznik, 2018, Future oncology.

PIN177 Identifying the Baseline Characteristics of Heart Failure Patients That Receive or Do NOT Receive the Seasonal Influenza Vaccine: A Study of Three Consecutive FLU Seasons

A. Galaznik, G. Ekong, R. Jain, 2020, Value in Health.

HSR19-084: Real-World Treatment Patterns and Clinical Outcomes in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations

A. Galaznik, M. Duh, S. Li, 2019, Journal of the National Comprehensive Cancer Network.

HSR19-082: Epidemiological Findings and Outcomes in Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations: A Meta-Analysis

A. Forsythe, A. Galaznik, D. Tomaras, 2019, Journal of the National Comprehensive Cancer Network.

P3.15-03 Capturing the Patient Experience for the Treatment of EGFR Exon 20 Mutations in Non-Small Cell Lung Cancer

A. Galaznik, D. Revicki, S. Li, 2018, Journal of Thoracic Oncology.